Physician profile
Michael Swift
NPI 1386995603
$13,199.86
in general payments reported to CMS, 2019-2025
9 companies · $37.00 in 2025
The $37.00 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,770 · 2022: $793 · 2023: $232 · 2024: $7,367 · 2025: $37.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,867 · Travel and Lodging: $2,051 · Food and Beverage: $709 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,867.31 |
| Travel and Lodging | $2,051.49 |
| Food and Beverage | $708.85 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,171.04 | 2021-2024 | |
| Boston Scientific Corporation | $766.98 | 2021-2022 | |
| Axonics, INC. | $75.60 | 2023 | Bulkamid, Axonics |
| Abbvie INC. | $59.99 | 2022-2025 | |
| Coopersurgical, INC. | $46.36 | 2021-2022 | |
| Pfizer INC. | $23.04 | 2023 | |
| Organon LLC | $22.21 | 2023 | Nexplanon |
| Laborie Medical Technologies Corp. | $18.19 | 2023 | |
| Exact Sciences Corporation | $16.45 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Swift listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.